UPFRONT TREATMENT OF HIGH RISK NEUROBLASTOMA WITH 131I-MIBG THERAPY AND TOPOTECAN. A PHASE I-II PILOT WINDOW STUDY (AMRO-NB-HR-2000/01)

K Kraal, J de Kraker, C Hoefnagel, B Van Eck-Smit, H Caron, M Van Noesel, G Tytgat

Research output: Contribution to journal › Article › Academic › peer-review

Cite this

@article{aea8e5175bd44ae49f00c98aa4aa2f13,

title = "UPFRONT TREATMENT OF HIGH RISK NEUROBLASTOMA WITH 131I-MIBG THERAPY AND TOPOTECAN. A PHASE I-II PILOT WINDOW STUDY (AMRO-NB-HR-2000/01)",

author = "K Kraal and {de Kraker}, J and C Hoefnagel and {Van Eck-Smit}, B and H Caron and {Van Noesel}, M and G Tytgat",

year = "2013",

language = "Undefined/Unknown",

volume = "60",

pages = "2--3",

journal = "Pediatric Blood and Cancer",

issn = "1545-5009",

publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - UPFRONT TREATMENT OF HIGH RISK NEUROBLASTOMA WITH 131I-MIBG THERAPY AND TOPOTECAN. A PHASE I-II PILOT WINDOW STUDY (AMRO-NB-HR-2000/01)

AU - Kraal, K

AU - de Kraker, J

AU - Hoefnagel, C

AU - Van Eck-Smit, B

AU - Caron, H

AU - Van Noesel, M

AU - Tytgat, G

PY - 2013

Y1 - 2013

M3 - Article

SN - 1545-5009

VL - 60

SP - 2

EP - 3

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

ER -